Skip to main content
Clinical Trials/CTRI/2022/09/045429
CTRI/2022/09/045429
Completed
Phase 2

Evaluation of Efficacy and Safety of Namaskar Ayurved Restore and Refresh Vetiver Concentrate in Healthy participants for its skin soothing and hydration activities- An open label, non-comparative, interventional, prospective, clinical study - NI

amaskar Ayurved Private Limited0 sites36 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
amaskar Ayurved Private Limited
Enrollment
36
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
October 12, 2022
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
amaskar Ayurved Private Limited

Eligibility Criteria

Inclusion Criteria

  • 1\.Healthy Male and female subjects
  • 2\.Willing to comply with all requirements of the study.

Exclusion Criteria

  • 1\.Subjects with a known current history of chronic skin diseases or autoimmune diseases, such as atopic dermatitis, psoriasis, chronic urticaria, vitiligo and rosacea
  • 2\.Subjects with a tattoo, a scar, moles, too many hairs or anything on the Right leg which might interfere with the evaluation.
  • 3\.Subjects with intensive exposure to sunlight or UV\-rays within the previous month and foreseen during the study.
  • 4\.Subjects who have used facial skin hydrating and soothing products (topicals), moisturizing cream, lotion or oil within 21 days before entering the trial
  • 5\.Subjects on any other investigational products within 1 month prior to randomization
  • 6\.Subjects with known current tuberculosis, HIV, ischemic heart disease, cancer, kidney failure, liver failure
  • 7\.Pregnant and lactating women
  • 8\.Known hypersensitivity to any of the ingredients of Namaskar Ayurved Restore and Refresh Vetiver Concentrate
  • 9\.Other conditions, which in the opinion of the investigators, make patient unsuitable for enrolment or could interfere with his/her participation in, and completion of the study

Outcomes

Primary Outcomes

Not specified

Similar Trials